術前化学療法後もしくは化学放射線療法後の直腸癌切除検体における腫瘍微小環境は再発を予測する因子になりうる

今泉 健; 鈴木 利宙; 下村 真奈美; 塚田 祐一郎; 佐々木 剛志; 西澤 祐吏; 小嶋 基寛; 伊藤 雅昭; 中面 哲也

doi:10.11241/jsmtmr.33.42

Immunological features of resected tumor after neoadjuvant chemotherapy (NAC) and chemoradiotherapy (CRT) become the superior prediction markers for recurrence in rectal cancer

Ken Imaizumi, Toshihiro Suzuki, Manami Shimomura, Yuichiro Tsukada, Takeshi Sasaki, Yuji Nishizawa, Motohiro Kojima, Masaaki Ito, Tetsuya Nakatsura

Author information

Ken Imaizumi
Divison of Colorectal Surgery, National Cancer Center Hospital East
Toshihiro Suzuki
Division of Cancer Immunotherapy, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center
Manami Shimomura
Division of Cancer Immunotherapy, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center
Yuichiro Tsukada
Divison of Colorectal Surgery, National Cancer Center Hospital East
Takeshi Sasaki
Divison of Colorectal Surgery, National Cancer Center Hospital East
Yuji Nishizawa
Divison of Colorectal Surgery, National Cancer Center Hospital East
Motohiro Kojima
Division of Pathology, National Cancer Center Hospital East
Masaaki Ito
Divison of Colorectal Surgery, National Cancer Center Hospital East
Tetsuya Nakatsura
Division of Cancer Immunotherapy, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center

JOURNAL FREE ACCESS

2018 Volume 33 Pages 42-43

DOI https://doi.org/10.11241/jsmtmr.33.42

Details

Corresponding author

Correction information

Register with J-STAGE for free!